We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Empower yourself with knowledge about genetic testing for ovarian cancer. Learn about risk factors, the role of genetic counselors, and how this vital tool can help protect your health.

Ovarian cancer, a silent threat that often strikes without obvious early warning signs, is a deeply concerning condition for women worldwide, and India is no exception. While the thought of cancer can be overwhelming, advancements in medical science offer new hope and proactive strategies. One such powerful tool is genetic testing. Have you ever wondered if you or your loved ones might be at a higher risk for ovarian cancer due to inherited factors? This guide is designed to shed light on genetic testing for ovarian cancer, specifically for our Indian readers, breaking down complex information into clear, actionable insights. We’ll explore what genetic testing entails, why it’s becoming increasingly important, and how it can empower you to take control of your health. What is Ovarian Cancer? Before we dive into genetic testing, let’s briefly touch upon ovarian cancer itself. This cancer originates in the ovaries, the female reproductive organs that produce eggs. It’s often called a “silent killer” because its early symptoms can be vague and easily mistaken for common ailments like indigestion or bloating. By the time it’s diagnosed, it has often spread, making treatment more challenging. What is Genetic Testing for Ovarian Cancer? Genetic testing involves analyzing your DNA to look for specific changes, or mutations, in your genes that can increase your risk of developing certain diseases, including ovarian cancer. Think of your genes as instruction manuals for your body. Sometimes, there are typos or errors in these manuals that can predispose you to certain conditions. Genetic testing helps identify these specific typos. The Evolution of Genetic Testing: From BRCA1/2 to Panel Testing When genetic testing for hereditary cancer risks first emerged, the focus was primarily on two genes: BRCA1 and BRCA2. These genes are well-known for their significant association with an increased risk of ovarian and breast cancers. However, medical research hasn't stood still! Today, the landscape of genetic testing has expanded dramatically. We now have “panel tests” that examine a much larger set of genes – sometimes 20, 50, or even up to 80 genes! These comprehensive panels can identify mutations in various genes that contribute to hereditary cancer syndromes, offering a more complete picture of an individual’s risk. Why the expansion? Because we’ve learned that ovarian cancer, like many other hereditary cancers, can be linked to mutations in a variety of genes, not just BRCA1 and BRCA2. These panels help us catch a wider net of potential risks. Who Should Consider Genetic Testing for Ovarian Cancer? Historically, doctors relied heavily on personal and family history of cancer to identify individuals who might benefit from genetic testing. If you had a close relative with ovarian, breast, or certain other cancers, you’d be a prime candidate. However, research has shown that this approach isn’t always enough. Key Insight: A significant portion of individuals with hereditary cancer syndromes, such as Lynch syndrome (formerly known as hereditary nonpolyposis colorectal cancer) or King syndrome (hereditary breast and ovarian cancer syndrome), do not have a clear personal or family history that fits the classical definition. This means relying solely on family history can miss many at-risk individuals. The current guideline is broad and inclusive: Any woman who has had ovarian cancer is now eligible for genetic testing. This is a monumental shift, ensuring that more women can access this vital information. Risk Factors that Guide Testing Decisions: Personal History: Having been diagnosed with ovarian cancer, or certain other cancers like breast, pancreatic, or prostate cancer. Family History: A history of ovarian, breast (especially premenopausal or bilateral), pancreatic, prostate, or melanoma in close relatives (mother, sister, daughter, father, brother, son). Ethnicity: Certain ethnic groups, like those of Ashkenazi Jewish descent, have a higher prevalence of BRCA mutations. Specific Diagnoses: Conditions like Lynch syndrome or hereditary breast and ovarian cancer syndrome. The Role of a Genetic Counselor: Your Expert Guide Navigating the world of genetic testing can feel complex. This is where genetic counselors play an indispensable role. These professionals hold specialized master's degrees and possess deep expertise in how genes function and the intricacies of genetic testing. They are trained to interpret test results, explain their implications, and discuss management options with you and your family. Why are they so important? As more companies offer genetic testing, the availability of experts who can accurately interpret these results hasn't kept pace. Genetic counselors are the trusted experts who can help you make sense of ambiguous findings, like a “variant of uncertain significance” (VUS), and guide your medical decisions. What is a Variant of Uncertain Significance (VUS)? Sometimes, genetic tests reveal a change in a gene that hasn't yet been clearly classified as either harmful or harmless. This is called a VUS. It can take years of research to determine the exact impact of a VUS. Genetic counselors are crucial in helping you understand what a VUS means in your specific context and how it should (or shouldn't) influence your healthcare decisions. What Specific Genes are Tested? As mentioned, panel tests look at a range of genes. The specific genes included in a panel can vary, but they are chosen based on their known association with increased cancer risk. The goal is to cover genes linked to the cancers seen in the patient or their family members. Considerations for Panel Size: While broader panels can detect more potential risks, they also increase the likelihood of finding a VUS. Your healthcare provider and genetic counselor will help determine the most appropriate panel for you, balancing the desire for comprehensive information with the potential for ambiguity. Benefits of Genetic Testing Understanding your genetic predisposition to ovarian cancer offers several powerful benefits: Informed Decision-Making: Knowledge is power. Genetic testing provides concrete information about your risk, allowing you to make informed choices about your health management. Personalized Screening: Based on your results, your doctor can recommend a more tailored and intensive screening schedule. This might include more frequent check-ups, specific imaging tests, or earlier screening than generally advised. Preventive Strategies: For those with a high-risk genetic mutation, options like risk-reducing surgeries (e.g., removal of ovaries and fallopian tubes) or medications might be considered. Family Planning: If you have a known mutation, your genetic counselor can discuss options like preimplantation genetic diagnosis (PGD) for those planning families. Empowerment for Relatives: Your test results can be invaluable for your blood relatives, allowing them to assess their own risk and pursue testing if indicated. The Cost of Genetic Testing in India The cost of genetic testing has seen a dramatic reduction over the years. What once cost thousands of dollars can now often be done for a significantly lower amount, sometimes as low as ₹15,000 - ₹20,000 or even less in India, depending on the specific test and provider. Insurance coverage can vary, so it’s essential to check with your provider and the testing facility. Can Birth Control Pills Reduce Ovarian Cancer Risk? Yes! This is a remarkable finding. Studies have shown that using oral contraceptives (birth control pills) can significantly reduce the risk of both ovarian and endometrial cancers, by at least 50 percent! This is a powerful example of how medical interventions can have a profound impact on cancer prevention. What About Previous Testing? If you had genetic testing 10, 15, or even 20 years ago, and it only included BRCA1 and BRCA2, it might be time to reconsider. Testing technology has advanced significantly. Mutations that were undetectable in the past can now be identified. If your previous test was limited, discussing updated testing with your doctor or genetic counselor is highly recommended. When to Consult a Doctor It’s always wise to discuss your concerns and family history with your doctor. Specifically, you should seek medical advice if: You have a strong family history of ovarian, breast, or other related cancers. You have been diagnosed with ovarian cancer. You have concerns about your personal risk factors. You had genetic testing years ago and want to know if updated testing is needed. Your doctor can guide you on whether genetic testing is appropriate and refer you to a genetic counselor if necessary. Frequently Asked Questions (FAQ) Q1: Is genetic testing for ovarian cancer only for women with a family history? A1: Not anymore. While family history is a strong indicator, current guidelines state that any woman diagnosed with ovarian cancer is eligible for genetic testing, regardless of family history. This broadens access significantly. Q2: What if my genetic test shows a Variant of Uncertain Significance (VUS)? A2: A VUS means a gene change was found, but its impact on cancer risk is not yet clear. It’s crucial not to make major medical decisions based solely on a VUS. Consult your genetic counselor to understand its implications and discuss ongoing monitoring or management strategies. Q3: Can genetic testing predict with 100% certainty that I will get ovarian cancer? A3: No, genetic testing identifies an *increased risk*, not a certainty. Having a mutation means your chances of developing ovarian cancer are higher than the general population, but it doesn't guarantee
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026